Drug shortage
Conivaptan Hydrochloride Injection · Cumberland Pharmaceuticals Inc.
FDA drug shortage · Current · updated Sep 16, 2026
Key facts
| Generic name | Conivaptan Hydrochloride Injection |
|---|---|
| Company | Cumberland Pharmaceuticals Inc. |
| Presentation | Vaprisol Dextrose In Plastic Container, Injection, 20 mg/100 mL (NDC 66220-160-10) |
| Dosage form | Injection |
| Status | Current |
| Reason for shortage | Delay in shipping of the drug |
| Therapeutic category | Cardiovascular |
| Package NDCs | 66220-160-10 |
| First posted | Mar 14, 2022 |
| Last updated | Sep 16, 2026 |
At a glance
- 1–9 Package NDCs affected
- 1–9 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: